⚠ For informational purposes only — not a substitute for professional medical advice. Emergencies: 911 or Poison Control 1-800-222-1222.
Drug Identification System
Pill Identifier Pill Guide Drug Encyclopedia Drug Classes Interactions Compare Blog Search
SSRI Head-to-Head · Half-Life, Interactions & Approved Uses

Lexapro vs Prozac: Key Differences Between These Two SSRIs

Escitalopram (Lexapro) and fluoxetine (Prozac) are both first-line SSRIs, but they are not interchangeable. Their half-lives differ by a factor of roughly five, their drug interaction profiles are very different, and their FDA approvals cover distinct conditions. Here is a direct comparison of what matters clinically.

Same class, different pharmacokinetics: Both drugs block the serotonin transporter (SERT), raising synaptic serotonin levels. The critical difference is half-life — Prozac's is five to ten times longer than Lexapro's — and CYP2D6 inhibition, which gives Prozac a much larger interaction footprint.

Both: generic available Both: once-daily dosing Onset: 2–6 weeks Prozac: strong CYP2D6 inhibitor Rx only
Side-by-side comparison

Lexapro vs Prozac at a Glance

Scroll horizontally on small screens. Both drugs require a prescription and should only be started, adjusted, or stopped under prescriber supervision.

Category Lexapro (escitalopram) Prozac (fluoxetine)
Generic name Escitalopram Fluoxetine
Drug class SSRI SSRI
Selectivity Highest of any SSRI — pure S-enantiomer of citalopram High SERT selectivity; also acts on additional receptors
Half-life ~27–32 hours ~4–6 days (fluoxetine)
+ norfluoxetine active metabolite: ~4–16 days
Available strengths 5 mg, 10 mg, 20 mg tablets
5 mg/5 mL oral solution 		10 mg, 20 mg, 40 mg capsules
10 mg tablets; 20 mg/5 mL oral solution
90 mg delayed-release weekly capsules (Prozac Weekly)
FDA-approved uses
  • MDD (adults + adolescents 12+)
  • GAD (adults)
  • MDD (adults + children 8+)
  • OCD (adults + children 7+)
  • Bulimia nervosa
  • Panic disorder
  • PMDD (weekly formulation)
  • Bipolar depression (+ olanzapine)
CYP2D6 inhibition Weak — minimal interaction burden; preferred for polypharmacy Strong — can significantly raise levels of co-administered CYP2D6 substrates
Discontinuation risk Moderate — shorter half-life means more risk if stopped abruptly Low — longest half-life of all SSRIs; self-tapering effect
Weight effects Modest weight gain possible over long term (typical of SSRIs) Weight-neutral to slight weight loss short-term; possible gain long-term
Insomnia / activation Less activating — neutral sleep profile More activating — can cause insomnia or agitation, especially early on
Generic available Yes — widely available, inexpensive Yes — widely available, inexpensive
Pediatric approval MDD: ages 12+ MDD: ages 8+; OCD: ages 7+

Available strengths shown above. How strengths are selected and adjusted is determined by your prescriber based on your individual clinical situation.

The defining pharmacokinetic difference

Half-Life: Why It Matters More Than It Sounds

Half-life controls how long a drug stays in your system and — critically — what happens when you stop taking it. This is where Lexapro and Prozac diverge most sharply.

Lexapro (escitalopram)
27–32 hours (parent drug)

Clears in roughly 5–7 days after stopping. Abrupt discontinuation carries a moderate risk of discontinuation symptoms (dizziness, flu-like feeling, "brain zaps"). Tapering is recommended.

Prozac (fluoxetine)
4–6 days (parent drug) + active metabolite norfluoxetine: 4–16 days

The longest half-life of any SSRI. Blood levels decline so slowly after stopping that the drug essentially tapers itself — this gives Prozac the lowest discontinuation syndrome risk of all SSRIs. Also the basis for its once-weekly formulation.

Clinical takeaway: If a patient has previously struggled with discontinuation symptoms on other SSRIs, Prozac's self-tapering pharmacology makes it a strong candidate. Conversely, Prozac's long half-life means it takes longer to fully wash out if a switch to another medication is needed — something prescribers factor in when changing regimens.

Drug interactions

CYP2D6 Inhibition: Lexapro's Biggest Advantage

Prozac: Strong CYP2D6 Inhibitor — Clinically Significant Interactions

Prozac (fluoxetine) is one of the most potent inhibitors of the CYP2D6 liver enzyme among commonly prescribed drugs. CYP2D6 metabolizes a wide range of medications, so Prozac can raise the blood levels of those drugs — sometimes substantially — increasing the risk of their side effects or toxicity.

Lexapro (escitalopram) is only a weak CYP2D6 inhibitor. For patients already taking multiple medications — a situation clinicians call polypharmacy — Lexapro is the preferred SSRI precisely because it is less likely to disrupt other drug levels.

Lexapro — interaction burden
  • Weak CYP2D6 inhibition
  • Very few clinically significant interactions
  • Preferred in polypharmacy settings
  • QTc prolongation at high doses (mild)
Prozac — notable CYP2D6 substrates affected
  • Tricyclic antidepressants (TCAs)
  • Many antipsychotics (risperidone, haloperidol)
  • Codeine / tramadol (reduces efficacy)
  • Certain beta-blockers (metoprolol)
  • Some antiarrhythmics
  • Tamoxifen (potential efficacy reduction)
Individual drug profiles

Each Drug in Depth

escitalopram
Lexapro Generic widely available · Forest / Allergan (brand)
Half-life 27–32 h
CYP inhibition Weak 2D6
MDD GAD Off-label: panic, social anxiety, OCD

Escitalopram is the S-enantiomer of citalopram — by isolating the active enantiomer, it achieves the highest SERT selectivity of any SSRI. Fewer off-target receptor interactions translate to a cleaner side effect profile for many patients.

Its minimal CYP footprint makes it the go-to SSRI when a patient is already on multiple medications. It is FDA-approved for GAD in adults, which Prozac is not — this gives it an advantage when anxiety is the primary complaint.

Strengths available: 5 mg, 10 mg, 20 mg tablets; 5 mg/5 mL oral solution. Strength selection is a clinical decision made by your prescriber.

fluoxetine
Prozac Generic widely available · Eli Lilly (brand)
Half-life 4–6 days
CYP inhibition Strong 2D6
MDD OCD Bulimia Panic disorder PMDD Bipolar depression

Fluoxetine's defining characteristic is its extraordinarily long half-life — including its active metabolite norfluoxetine, it can persist in the body for weeks. This makes it the SSRI least likely to cause discontinuation syndrome, and the basis for its convenient once-weekly formulation.

Prozac holds more FDA approvals than any other SSRI: it is the only one approved for bulimia nervosa, for pediatric depression in children as young as 8, and for bipolar depression as an adjunct to olanzapine. Its stimulating properties can be an advantage for patients with fatigue or hypersomnia, or a drawback if insomnia is already a problem.

Strengths available: 10 mg, 20 mg, 40 mg capsules; 10 mg tablets; 20 mg/5 mL oral solution; 90 mg delayed-release weekly capsules (Prozac Weekly). Strength selection is a clinical decision made by your prescriber.

Clinical scenarios

Which Is Preferred in Specific Situations?

These are general clinical tendencies, not individual recommendations. Only your prescriber can determine the right choice for your situation.

Lexapro tends to be preferred when…
  • ► Generalized anxiety disorder is the primary diagnosis — Lexapro carries an FDA approval for GAD
  • ► Patient is on multiple other medications (polypharmacy) — fewer CYP interactions
  • ► Insomnia or anxiety about side effects — cleaner receptor profile
  • ► Antidepressant-naive patients where tolerability is a top priority
Prozac tends to be preferred when…
  • ► Bulimia nervosa is being treated — Prozac is the only SSRI approved for this
  • ► Discontinuation syndrome is a concern — self-tapering pharmacology
  • ► Pediatric patients aged 8–11 with depression (Prozac approved; Lexapro is 12+)
  • ► Fatigue or hypersomnia are prominent symptoms — activating profile may help
  • ► PMDD — weekly Prozac formulation is approved specifically for this
Bottom line

What Each Drug Does Best

Lexapro (escitalopram)
Cleanest side effect profile of the two — highest SSRI receptor selectivity
Fewest drug interactions — the right choice when polypharmacy is a factor
FDA-approved for GAD — first-line for generalized anxiety
Widely considered the most tolerable SSRI for new starters
Prozac (fluoxetine)
Lowest discontinuation risk of all SSRIs — long half-life means self-tapering
Only SSRI approved for bulimia nervosa
Broadest FDA approval set — MDD, OCD, bulimia, panic, PMDD, bipolar depression
Approved for pediatric depression starting at age 8 (Lexapro: age 12)
Activating effect benefits patients with fatigue or low energy
Frequently asked questions

Common Questions About Lexapro vs Prozac

What is the biggest difference between Lexapro and Prozac?
The single most clinically meaningful difference is half-life. Prozac (fluoxetine) has an exceptionally long half-life — roughly 4 to 6 days — partly because it produces an active metabolite called norfluoxetine that lasts even longer. This makes Prozac the SSRI with the lowest risk of discontinuation syndrome when stopping. Lexapro (escitalopram), with a half-life of about 27 to 32 hours, is more likely to cause discontinuation symptoms if stopped abruptly. Prozac is also a strong CYP2D6 inhibitor, meaning it interacts with more other medications than Lexapro does.
Is Lexapro or Prozac better for anxiety?
Lexapro (escitalopram) holds an explicit FDA approval for generalized anxiety disorder (GAD) and is often considered a first-line choice for anxiety conditions. Prozac (fluoxetine) is FDA-approved for panic disorder and is widely used off-label for anxiety, but it lacks a dedicated GAD approval. For GAD specifically, Lexapro is often preferred. For panic disorder, both are reasonable options. Individual response varies, and the right choice depends on the full clinical picture.
Which is easier to stop — Lexapro or Prozac?
Prozac (fluoxetine) is by far the easier SSRI to discontinue. Its extremely long half-life — 4 to 6 days for fluoxetine, even longer for its active metabolite norfluoxetine — means blood levels taper gradually on their own, which substantially reduces the risk of discontinuation syndrome (sometimes called SSRI withdrawal). Lexapro has a shorter half-life of about 27 to 32 hours, so it clears more quickly and carries a higher risk of discontinuation symptoms if stopped abruptly. Always taper any antidepressant under prescriber guidance.
Does Prozac cause more drug interactions than Lexapro?
Yes. Prozac (fluoxetine) is a strong inhibitor of the CYP2D6 liver enzyme, which metabolizes a large number of common medications including many antidepressants, antipsychotics, opioids, beta-blockers, and antiarrhythmics. Adding Prozac can raise blood levels of those drugs to potentially problematic concentrations. Lexapro (escitalopram) has a much lighter interaction footprint — it is only a weak CYP2D6 inhibitor and has very few clinically significant interactions. For patients on multiple medications (polypharmacy), Lexapro is generally preferred.
Is Prozac approved for bulimia nervosa?
Yes — Prozac (fluoxetine) is the only antidepressant with an FDA approval specifically for bulimia nervosa, making it the standard pharmacologic treatment for that condition. Lexapro does not carry this approval. Prozac is also the only SSRI FDA-approved for pediatric depression (ages 8 and up) and for bipolar depression as an adjunct to olanzapine.
Which SSRI has a cleaner side effect profile — Lexapro or Prozac?
Lexapro (escitalopram) is generally regarded as having the cleanest side effect profile of the two — and arguably of any SSRI — due to its exceptional selectivity for the serotonin transporter. Prozac acts on additional receptors beyond SERT, which contributes to side effects like agitation, insomnia, and changes in weight. Both drugs produce the common SSRI side effects: nausea, sexual dysfunction, and headache. Real-world tolerability is highly individual; what causes side effects in one person may be well tolerated by another.
Medical disclaimer

Important Notice

Not medical advice

This page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Information about available strengths is not a guide to selecting or adjusting doses — that is a clinical decision made by a licensed prescriber based on your individual health situation. Never start, stop, or change a psychiatric medication without guidance from your prescriber or pharmacist. If you are experiencing a medical emergency, call 911. For poison-related emergencies, call Poison Control at 1-800-222-1222.